Shu Wei

Title: Innovations of Inventor Shu Wei in Hydrogel Technology.

Introduction

Shu Wei is a prominent inventor based in Hangzhou, China. He has made significant contributions to the field of hydrogel technology, particularly through his innovative patent related to cis-platinum cross-linked protein hydrogels. His work focuses on enhancing drug delivery systems while minimizing potential side effects.

Latest Patents

Shu Wei holds a patent for a cis-platinum cross-linked protein hydrogel and its preparation method. This invention involves a hydrogel that comprises 0.5% to 5.0% drug, 6.0% to 50.0% serum albumin, and 47.0% to 93.0% solvent medium. The unique feature of this hydrogel is the formation of a coordinate bond between a carboxyl group on the serum albumin surface and the cis-platinum drug. This innovative approach not only simplifies the hydrogel's structure but also serves dual purposes: acting as a cross-linking agent and an antitumor drug. The design effectively limits the burst release of the drug, thereby reducing potential toxic side effects.

Career Highlights

Shu Wei is affiliated with Hangzhou Normal University, where he continues to advance his research in hydrogel technology. His work has garnered attention for its practical applications in the medical field, particularly in cancer treatment.

Collaborations

Shu Wei collaborates with notable colleagues such as Shuangjiang Yu and An Yan, contributing to a dynamic research environment that fosters innovation and development in hydrogel applications.

Conclusion

Shu Wei's contributions to hydrogel technology exemplify the intersection of innovation and practical application in medicine. His work not only advances scientific understanding but also holds promise for improving patient outcomes in cancer treatment.